Nora Zizlsperger

Nora Zizlsperger has a diverse work experience spanning over 20 years. Nora currently serves as the Director Clinical Sciences at Infinity Pharmaceuticals since April 2020. Prior to that, they held multiple roles at Compass Therapeutics LLC, including Associate Director of Clinical Research, Principal Scientist, and Senior Scientist from 2015 to 2020. Before joining Compass Therapeutics, Nora worked at EMD Serono, Inc. as a Scientist from 2013 to 2015 and as a Postdoctoral Scientist from 2010 to 2013. Nora also worked at the Massachusetts Institute of Technology as a Graduate Student from 2004 to 2010 and at the Whitehead Institute as a Technical Assistant from 2002 to 2003. Nora started their career as a Research Associate at Syntonix Pharmaceuticals from 2000 to 2002.

Nora Zizlsperger pursued their education in a methodical manner, completing both their undergraduate and doctoral studies in the field of biology. Nora began their academic journey at Simmons University from 1996 to 2000, where they obtained a Bachelor of Science degree in Biochemistry. Building on this foundation, Nora attended the prestigious Massachusetts Institute of Technology from 2003 to 2010, culminating in the completion of their Ph.D. in Biology. Throughout their education, Nora focused their studies on the biological sciences, steadily progressing and deepening their understanding in this field.